Tissue engineering and cell based therapies, from the bench to the clinic: The potential to replace, repair and regenerate

被引：91
作者：
William L Fodor
机构：
[1] Center for Regenerative Biology, Department of Molecular/Cell Biology, University of Connecticut, Storrs
来源：
Reproductive Biology and Endocrinology | / 1卷 / 1期
关键词：
Spinal Cord Injury; Neural Stem Cell; Retinal Pigment Epithelial Cell; Mycosis Fungoides; Articular Cartilage Defect;
D O I：
10.1186/1477-7827-1-102
中图分类号：
学科分类号：
摘要：
The field of Regenerative Biology as it applies to Regenerative Medicine is an increasingly expanding area of research with hopes of providing therapeutic treatments for diseases and/or injuries that conventional medicines and even new biologic drug therapies cannot effectively treat. Extensive research in the area of Regenerative Medicine is focused on the development of cells, tissues and organs for the purpose of restoring function through transplantation. The general belief is that replacement, repair and restoration of function is best accomplished by cells, tissues or organs that can perform the appropriate physiologic/metabolic duties better than any mechanical device, recombinant protein therapeutic or chemical compound. Several strategies are currently being investigated and include, cell therapies derived from autologous primary cell isolates, cell therapies derived from established cell lines, cell therapies derived from a variety of stem cells, including bone marrow/mesenchymal stem cells, cord blood stem cells, embryonic stem cells, as well as cells tissues and organs from genetically modified animals. This mini-review is not meant to be exhaustive, but aims to highlight clinical applications for the four areas of research listed above and will address a few key advances and a few of the hurdles yet to be overcome as the technology and science improve the likelihood that Regenerative Medicine will become clinically routine. © 2004 Fodor; licensee BioMed Central Ltd.
引用
收藏
页数：6
相关论文
共 96 条
  • [1] Brittberg M., Lindahl A., Nilsson A., Ohlsson C., Isaksson O., Peterson L., Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation, N. Engl. J. Med., 331, pp. 889-895, (1994)
  • [2] Brittberg M., Nilsson A., Lindahl A., Ohlsson C., Peterson L., Rabbit articular cartilage defects treated with autologous cultured chondrocytes, Clin. Orthop., pp. 270-283, (1996)
  • [3] Minas T., Chondrocyte implantation in the repair of chondral lesions of the knee: Economics and quality of life, Am. J. Orthop., 27, pp. 739-744, (1998)
  • [4] Brittberg M., Autologous chondrocyte transplantation, Clin. Orthop., (1999)
  • [5] Minas T., Peterson L., Advanced techniques in autologous chondrocyte transplantation, Clin. Sports Med., 18, pp. 13-44, (1999)
  • [6] Robinson D., Ash H., Aviezer D., Agar G., Halperin N., Nevo Z., Autologous chondrocyte transplantation for reconstruction of isolated joint defects: The Assaf Harofeh experience, Isr. Med. Assoc. J., 2, pp. 290-295, (2000)
  • [7] Brittberg M., Tallheden T., Sjogren-Jansson B., Lindahl A., Peterson L., Autologous chondrocytes used for articular cartilage repair: An update, Clin. Orthop., (2001)
  • [8] King P.J., Bryant T., Minas T., Autologous chondrocyte implantation for chondral defects of the knee: Indications and technique, J. Knee Surg., 15, pp. 177-184, (2002)
  • [9] Peterson L., Brittberg M., Kiviranta I., Akerlund E.L., Lindahl A., Autologous chondrocyte transplantation. Biomechanics and long-term durability, Am. J. Sports Med., 30, pp. 2-12, (2002)
  • [10] Peterson L., Minas T., Brittberg M., Lindahl A., Treatment of osteochondritis dissecans of the knee with autologous chondrocyte transplantation: Results at two to ten years, J. Bone Joint Surg. Am., 85 A, SUPPL. 2, pp. 17-24, (2003)
12345678910